AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Amoxineta-CV 625 Tablet

Prescription Icon
Prescription Required

Marketer

Aneta pharmaceuticals Pvt. Ltd

Salt Composition

Amoxycillin (500mg) + Clavulanic Acid (125mg)

Overview Amoxineta-CV 625 Tablet

Cefixime 625mg tablets are a bacterial infection fighter. They treat lung (like pneumonia), ear, sinus, urinary tract, skin, and soft tissue infections. This medication is ineffective against viral illnesses such as the common cold. For optimal stomach comfort, take Cefixime 625mg with food, following your doctor's prescribed schedule for consistent, evenly spaced doses. Consistent timing aids in remembering to take it. Dosage varies by condition, but always finish the full course as directed. Premature discontinuation can lead to infection recurrence or worsening due to surviving bacteria. Common side effects, typically mild, include nausea, diarrhea, vomiting, oral or genital yeast infections, rashes, and vaginal inflammation. Report persistent or bothersome side effects to your physician. Inform your doctor of any antibiotic allergies, kidney or liver issues, and all other medications you're using, as interactions are possible. Generally considered safe during pregnancy and breastfeeding under medical supervision.

Primary Ingredients of Amoxineta-CV 625 Tablet

No text was provided to rewrite.

Uses of Amoxineta-CV 625 Tablet

Combating Bacterial Infections

Major Benefits of Amoxineta-CV 625 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The Amoxineta-CV 625 Tablet should be swallowed whole; do not crush, chew, or break it. Administer this medication with food.

Common Side effects of Amoxineta-CV 625 Tablet:

  • Vaginal inflammation
  • Mucocutaneous candidiasis
  • Vomiting
  • Nausea
  • Diarrhea
  • Skin rash
  • Red spots or bumps
  • Fungal infection

How to use Amoxineta-CV 625 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Amoxineta-CV 625 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Amoxineta-CV 625 Tablet works:

Amoxineta-CV 625 tablets contain amoxicillin, an antibiotic, and clavulanic acid, a beta-lactamase inhibitor. Amoxicillin combats bacterial growth by disrupting the synthesis of their protective cell walls. Clavulanic acid counteracts bacterial resistance mechanisms, thereby improving amoxicillin's effectiveness.

SAFETY ADVICE

AlcoholAlcoholSAFE

Amoxineta-CV 625 Tablet consumption alongside alcohol poses no known adverse reactions.

PregnancyPregnancySAFE IF PRESCRIBED

The antibiotic Amoxineta-CV 625 Tablet is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data in humans are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Amoxineta-CV 625 Tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Amoxineta-CV 625 Tablet side effects, including allergic reactions, dizziness, or seizures.

KidneyKidneyCAUTION

Patients with kidney impairment should use Amoxineta-CV 625 Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised. Amoxineta-CV 625 Tablets are contraindicated in individuals with severe kidney disease.

LiverLiverCAUTION

Amoxineta-CV 625 Tablets require careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Routine monitoring of liver function is recommended during treatment.

What if you forget to take Amoxineta-CV 625 Tablet :

Should you forget a dose of Amoxineta-CV 625 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Amoxineta-CV 625 Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Agents against infection

FAQs on Amoxineta-CV 625 Tablet

Amoxycillin and clavulanate potassium (Amoxineta-CV 625 Tablet) combats various bacterial infections. Its dual-action formulation targets infections such as tonsillitis, sinusitis, middle ear infections, respiratory illnesses, urinary tract infections, skin boils and abscesses, cellulitis, wound infections, osteomyelitis, and oral infections. The medication's mechanism involves the eradication of disease-causing bacteria.
Amoxineta-CV 625 tablets are generally well-tolerated when administered according to a physician's instructions. Nevertheless, some individuals may encounter typical adverse reactions such as nausea, vomiting, diarrhea, skin rash, or allergic responses. Less frequent or infrequent side effects are also possible. Prompt medical consultation is recommended should any treatment-related issue persist.
Amoxineta-CV 625 Tablets are contraindicated in individuals with documented penicillin hypersensitivity or allergy to any component of the formulation. Patients with a history of hepatic impairment should also avoid this medication. Disclosure of any medication allergies to your physician is essential.
Amoxineta-CV 625 Tablets may reduce the effectiveness of oral contraceptives. Discuss alternative birth control options, such as condoms, diaphragms, or spermicides, with your physician while using this medication.
Exceeding the prescribed dosage of Amoxineta-CV 625 Tablet elevates the likelihood of adverse reactions. Amoxineta-CV 625 Tablet requires time to achieve maximum therapeutic benefit and resolve your infection. Should your symptoms worsen, seek immediate medical attention for reassessment.
Retain this medication within its original, securely sealed container or packaging. Follow the storage directions provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Discontinue Amoxineta-CV 625 Tablet only upon completing the prescribed regimen. Even with symptom improvement, premature cessation risks incomplete infection eradication. Continue the medication as directed; therapeutic benefits may persist despite feeling well.
Amoxineta-CV 625 Tablets may trigger allergic reactions and are contraindicated for individuals with penicillin allergies. Seek immediate medical attention if you experience symptoms such as hives, respiratory distress, or facial, lip, tongue, or throat swelling.
Amoxineta-CV 625 Tablets may induce diarrhea. This antibiotic eliminates harmful bacteria, but can also impact beneficial gut flora, leading to diarrhea. If diarrhea develops, increase fluid intake. Persistent diarrhea or signs of dehydration (infrequent urination, dark, strong-smelling urine) warrant immediate medical attention. Do not self-medicate.
Amoxineta-CV 625 Tablets are ineffective against viral illnesses such as influenza or the common cold. Seek professional medical advice; self-treating is inadvisable.
Amoxineta-CV 625 Tablets are not associated with drowsiness. Report any drowsiness experienced to your physician.
Amoxineta-CV 625 Tablet
106
MRP 123
13% off